BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$615M |
| 2 |
State Street SPDR S&P Retail ETF
XRT
|
+$231M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$229M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$186M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$620M |
| 3 |
Tesla
TSLA
|
+$594M |
| 4 |
Apple
AAPL
|
+$541M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.39% |
| 2 | Financials | 6.9% |
| 3 | Healthcare | 5.41% |
| 4 | Consumer Discretionary | 4.97% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALBO
2876
DELISTED
Albireo Pharma Inc
ALBO
| $216K | ﹤0.01% |
6,928
+1,843
| +36% | +$57K |
|
2877
TFS Financial
TFSL
$4.89B
| $216K | ﹤0.01% |
11,316
-5,186
| -31% | -$101K |
|
2878
Costamare
CMRE
$1.71B
| $215K | ﹤0.01% |
13,873
+7,345
| +113% | +$94.7K |
|
|
SAGE
2879
DELISTED
Sage Therapeutics
SAGE
| $215K | ﹤0.01% |
4,845
+2,886
| +147% | +$132K |
|
2880
nLIGHT
LASR
$2.9B
| $215K | ﹤0.01% |
7,611
+6,058
| +390% | +$180K |
|
2881
Horizon Bancorp
HBNC
$1.05B
| $214K | ﹤0.01% |
11,775
+5,744
| +95% | +$99.3K |
|
|
XRN
2882
Chiron Real Estate Inc
XRN
$484M
| $214K | ﹤0.01% |
2,910
-1,691
| -37% | -$129K |
|
|
TRTX
2883
TPG RE Finance Trust
TRTX
$610M
| $214K | ﹤0.01% |
17,259
+7,905
| +85% | +$101K |
|
|
TEN
2884
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $213K | ﹤0.01% |
14,915
+12,226
| +455% | +$197K |
|
2885
Manitowoc
MTW
$727M
| $212K | ﹤0.01% |
9,874
+4,188
| +74% | +$96.9K |
|
|
ENBL
2886
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
| $210K | ﹤0.01% |
25,911
+4,340
| +20% | +$35.4K |
|
|
MORF
2887
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $210K | ﹤0.01% |
3,714
+2,939
| +379% | +$178K |
|
|
UMH
2888
UMH Properties
UMH
$1.39B
| $210K | ﹤0.01% |
9,184
+7,585
| +474% | +$177K |
|
|
CIO
2889
DELISTED
City Office REIT
CIO
| $210K | ﹤0.01% |
11,754
-6,863
| -37% | -$99.9K |
|
|
ZGNX
2890
DELISTED
Zogenix, Inc.
ZGNX
| $209K | ﹤0.01% |
13,779
+6,740
| +96% | +$105K |
|
2891
CNA Financial
CNA
$13.7B
| $208K | ﹤0.01% |
4,968
-32,896
| -87% | -$1.44M |
|
2892
ACM Research
ACMR
$5.65B
| $208K | ﹤0.01% |
5,661
+5,004
| +762% | +$153K |
|
2893
Krystal Biotech
KRYS
$9.72B
| $205K | ﹤0.01% |
3,929
+3,202
| +440% | +$190K |
|
|
CCF
2894
DELISTED
Chase Corporation
CCF
| $205K | ﹤0.01% |
2,008
+1,334
| +198% | +$149K |
|
2895
Anavex Life Sciences
AVXL
$303M
| $205K | ﹤0.01% |
11,414
+9,169
| +408% | +$183K |
|
|
NIU
2896
Niu Technologies
NIU
$162M
| $204K | ﹤0.01% |
+8,787
| New | +$234K |
|
|
MRTX
2897
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $203K | ﹤0.01% |
1,148
+497
| +76% | +$80K |
|
2898
PUT
NIO
NIO
$11.3B
| $203K | ﹤0.01% |
57
| – | – |
|
2899
Syndax Pharmaceuticals
SNDX
$1.77B
| $203K | ﹤0.01% |
10,620
+7,502
| +241% | +$125K |
|
2900
iShares MSCI Singapore ETF
EWS
$1.16B
| $202K | ﹤0.01% |
8,889
| – | – |
|
Similar funds
BNP Paribas Financial Markets's Q3 2021 Portfolio in Review
As of Q3 2021, BNP Paribas Financial Markets held 4,161 positions worth $70.6B, down 6.6% from $75.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.5B in Q3 2021, closing 150 positions and reducing 1,194 holdings. Its most notable exit was GE Aerospace, an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares 10+ Year Investment Grade Corporate Bond ETF worth $5.86M.
- BNP Paribas Financial Markets's largest Q3 2021 buy was iShares 10+ Year Investment Grade Corporate Bond ETF: 84,600 shares worth $5.86M.
- BNP Paribas Financial Markets added most to iShares Russell 2000 ETF in Q3 2021, an estimated $615M increase.
- BNP Paribas Financial Markets's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.24B.
- BNP Paribas Financial Markets fully exited GE Aerospace in Q3 2021, selling an estimated $147M.
- BNP Paribas Financial Markets's ten largest holdings make up 14% of its $70.6B portfolio in Q3 2021.
- BNP Paribas Financial Markets opened 102 new positions and closed 150 in Q3 2021.
- BNP Paribas Financial Markets's portfolio value fell 6.6% quarter-over-quarter to $70.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2021, filed 12 Nov 2021.